MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,160,000 | -33.8% | 742,138 | -37.0% | 0.51% | -37.3% |
| Q2 2022 | $21,391,000 | -54.9% | 1,177,250 | -37.5% | 0.82% | -54.0% |
| Q1 2022 | $47,435,000 | -15.2% | 1,882,357 | -7.1% | 1.77% | -6.8% |
| Q4 2021 | $55,909,000 | -39.7% | 2,025,681 | -29.5% | 1.90% | -30.2% |
| Q3 2021 | $92,767,000 | -1.8% | 2,872,918 | -7.0% | 2.73% | -7.9% |
| Q2 2021 | $94,466,000 | +14.1% | 3,089,152 | +13.6% | 2.96% | +17.1% |
| Q1 2021 | $82,782,000 | +5881.4% | 2,718,623 | +6614.1% | 2.53% | +10012.0% |
| Q1 2014 | $1,384,000 | -83.8% | 40,491 | -90.0% | 0.02% | -85.4% |
| Q4 2013 | $8,520,000 | +140.0% | 406,103 | +19.0% | 0.17% | +101.2% |
| Q3 2013 | $3,550,000 | -59.7% | 341,376 | -33.8% | 0.08% | -70.9% |
| Q1 2013 | $8,804,000 | – | 515,468 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,309,206 | $109,866,000 | 6.94% |
| SG Capital Management LLC | 604,159 | $20,058,000 | 3.66% |
| KESTREL INVESTMENT MANAGEMENT CORP | 232,975 | $7,735,000 | 3.57% |
| Broadfin Capital, LLC | 500,000 | $16,600,000 | 3.43% |
| Tieton Capital Management, LLC | 98,199 | $3,260,000 | 2.90% |
| SG Capital Management LLC | 350,000 | $11,620,000 | 2.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,852,064 | $94,689,000 | 1.66% |
| Broadfin Capital, LLC | 240,000 | $7,968,000 | 1.64% |
| Millrace Asset Group, Inc. | 58,302 | $1,936,000 | 1.63% |
| PURA VIDA INVESTMENTS, LLC | 300,000 | $9,960,000 | 1.42% |